Article
Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
Journal of the National Comprehensive Cancer Network : JNCCN - 1 Jul 2016
Fay Andre P, de Velasco Guillermo, Ho Thai H, Van Allen Eliezer M, Murray Bradley, Albiges Laurence, Signoretti Sabina, Hakimi A Ari, Stanton Melissa L, Bellmunt Joaquim, McDermott David F, Atkins Michael B, Garraway Levi A, Kwiatkowski David J, Choueiri Toni K
Abstract excerpt
Advances in next-generation sequencing have provided a unique opportunity to understand the biology of disease and mechanisms of sensitivity or resistance to specific agents. Renal cell carcinoma (RCC) is a heterogeneous disease and highly variable clinical responses have been observed with vascular endothelial growth factor (VEGF)-targeted therapy (VEGF-TT). We hypothesized that whole-exome sequencing analysis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
